🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 15

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 15 of 20
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
May 12, 2025 at 2:19 PM#71

From the other side of the consultation, briefly. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

Ask again with the specifics and you will get a better answer than this one.

33 6nick_newbie, DadBodDave, AmyNC_wife and 30 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
May 20, 2025 at 4:26 PM#72
chris_chi24 said:
It helps to ask what evidence would change your mind before you look at any.

Mine went the same way, slower. Nothing to add that would improve it.

Last edited: May 20, 2025 at 9:26 PM
34 7raj_cambridge, ingrid_STO, pete_nash and 31 others
Reply Quote Save Share Report
JessicaM_2024
Member
823
3,456
Mar 2024
Portland, OR
May 28, 2025 at 6:28 PM#73
chris_chi24 said:
It helps to ask what evidence would change your mind before you look at any.

There is a second half to this that has not been said yet. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

35 8mike_mealprep, NicoleRaleigh, james_edin and 32 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Jun 5, 2025 at 8:26 PM#74

Old thread, but it comes up first when you search for this, so it is worth updating. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

36 9kate.chem, DataDave, Dr.GutHealth and 33 others
Reply Quote Save Share Report
emily_PDX
Member
245
1,123
Nov 2024
Portland, OR
Jun 13, 2025 at 10:19 PM#75

One thing that is still open after chris_chi24’s answer:

How would you tell the difference between that and the alternative explanation?

37 10PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 34 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register